Inhibition of prostacyclin by treatment of endothelium with aspirin. Correlation with platelet adherence

The Journal of Clinical Investigation
R L CzervionkeD L Haycraft

Abstract

Aspirin treatment of cultured endothelial cells from the umbilical vein increased the adherence of 51Cr-platelets when thrombin was present. If the cyclooxygenase activity of endothelium was inhibited by aspirin, as it is in the platelet, reduction of endogenous prostacyclin (PGI2) production could have been responsible. By correlating thrombin-induced adherence of platelets to endothelial monolayers with PGI2 release (as measured by radioimmunoassay for 6-keto-prostaglandin FI1 alpha [6-keto-PGF1 alpha]), we have demonstrated an inverse relationship between platelet adherence and PGI2 levels. Untreated endothelial monolayers exposed to thrombin and platelets resulted in 4% platelet adherence and 107 nM 6-keto-PGF1 alpha. With 0.1 mM aspirin treatment, which is known to block platelet cyclooxygenase, adherence was 5% and 6-keto-PGF1 alpha decreased to 45 nM. Increasing the aspirin concentration to 1 mM resulted in 44% adherence and less than 3 nM 6-keto-PGF1 alpha. When 25 nM exogenous PGI2 was added to 1 mM aspirin-treated endothelium, adherence returned to 5%. The increase in thrombin-induced platelet adherence to 1 mM aspirin-treated monolayers was reversed 2 h after removal of the aspirin solution. 6-Keto-PGF1 alpha returne...Continue Reading

References

Oct 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·J W BurchP W Majerus
Sep 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·B B WekslerE A Jaffe
Nov 1, 1978·The Journal of Clinical Investigation·B B WekslerE A Jaffe
Oct 1, 1978·The Journal of Clinical Investigation·R L CzervionkeG L Fry
Sep 9, 1977·Biochemical and Biophysical Research Communications·N L BaenzigerP W Majerus
Mar 1, 1972·Journal of Pharmaceutical Sciences·M RowlandS D Sholkoff
Jul 15, 1965·Biochimica Et Biophysica Acta·L L BennettR W Brockman

❮ Previous
Next ❯

Citations

Sep 1, 1985·Basic Research in Cardiology·K Schrör
Jan 1, 1990·Pharmacology & Therapeutics·G J Dusting, P S MacDonald
Sep 30, 1985·Biochimica Et Biophysica Acta·P G de GrootJ A Van Mourik
Jan 1, 1983·General Pharmacology·E A Higgs, S Moncada
Aug 1, 1995·Prostaglandins, Leukotrienes, and Essential Fatty Acids·R Imai-SasakiT Nakadate
Dec 1, 1987·Journal of Molecular and Cellular Cardiology·C M JohnsonS C Helgeson
Dec 22, 1979·Lancet·K MiwaC Kawai
Nov 6, 1980·The New England Journal of Medicine·T L Wenger, J H Hull
Sep 15, 1983·The New England Journal of Medicine
Jan 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·A F Brotherton, J C Hoak
Jan 30, 1988·British Medical Journal·M Orme
May 1, 1980·The Journal of Clinical Investigation·A A SpectorJ B Smith
Aug 1, 1983·The Journal of Clinical Investigation·R S KentA R Whorton
Jul 1, 1984·The Journal of Clinical Investigation·A Náray-Fejes-TóthJ C Frölich
Apr 1, 1989·The Journal of Clinical Investigation·A BarchowskyA R Whorton
Jun 1, 1995·Acta Orthopaedica Scandinavica. Supplementum·K A Vretos, A G Tsavissis
Apr 1, 1990·American Journal of Obstetrics and Gynecology·D J DudleyD W Branch
May 11, 2010·Thrombosis Research·James P SmithOlivier Boutaud
Jul 23, 2015·Prostaglandins & Other Lipid Mediators·Karsten Schrör, Bernhard H Rauch
Nov 1, 1983·Progress in Cardiovascular Diseases·S Niewiarowski, A K Rao
Jan 1, 1983·Thrombosis Research. Supplement·J C Hoak
Apr 1, 1980·Thrombosis Research·T KumadaY Abiko
Dec 1, 1987·British Journal of Pharmacology·J B WarrenS E Barrow
Jan 1, 1982·Annals of the New York Academy of Sciences·J Hirsh
Apr 15, 2015·Vascular Pharmacology·A A PettersenI Seljeflot
Jan 1, 1986·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·J H ReindersP G de Groot
Mar 1, 1983·Stroke; a Journal of Cerebral Circulation·S Moncada

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.